Statement from FDA Commissioner Scott Gottlieb, M.D. responding to report from GAO and updating on FDA’s ongoing efforts to increase access to complex generic drugs

GAO issued the report “Generic Drugs: FDA Should Make Public Its Plans to Issue and Revise Guidance on Nonbiological Complex Drugs,” which contains a single recommendation for the FDA — that the agency publicly announce its plans to issue or revise guidance for these drug products. The FDA agrees and is actively working to accomplish this goal.

Hiland Dairy Announces Voluntary Recall Of Hiland Dairy Orange Juice And Tampico Citrus Punch

Hiland Dairy is announcing a voluntary recall of two products produced at the Omaha, Nebraska facility, over concerns the products may contain milk protein that could affect those individuals that have sensitivity to milk allergens. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume these products. No illnesses or allergic reactions have been reported at this time.

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA decision to seek additional time to reassess rule that would have changed longstanding practices for how the agency determined the ‛intended use’ of medical products

: FDA decision to seek additional time to reassess rule that would have changed longstanding practices for how the agency determined the ‛intended use’ of medical products

Fieldbrook Foods Corporation Clarifies Scope of its Voluntary Recall. Products Include Orange Cream

Fieldbrook Foods Corporation is clarifying that the previously announced voluntary recall of all orange cream bars
and chocolate coated vanilla ice cream bars that were produced in 2017 on the company’s Hoyer 1 Line at its
Dunkirk, NY plant (plant code 362677) also includes 28,751 cases of Raspberry Cream Bars that were included
with Orange Cream Bars in ALDI seasonal split-case purchases.